HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Kilgo Selected Research

Glycoproteins (Glycoprotein)

10/2001Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Kilgo Research Topics

Disease

1Acquired Immunodeficiency Syndrome (AIDS)
10/2001

Drug/Important Bio-Agent (IBA)

1VaxSyn HIV-1 (gp160) vaccineIBA
10/2001
1Glycoproteins (Glycoprotein)IBA
10/2001
1VaccinesIBA
10/2001